Le Lézard
Classified in: Health, Business
Subjects: NPT, CHI, CXP

Phoenix Children's Earns a Highest-Achievable Three-Year Accreditation for Inpatient Rehabilitation Services


PHOENIX, Oct. 8, 2019 /PRNewswire/ -- Phoenix Children's Hospital has received a three-year accreditation from the Commission on Accreditation of Rehabilitation Facilities (CARF). CARF International is an independent nonprofit accreditor of health and human services aimed at raising care standards for service providers.

"We're thrilled to achieve this accreditation," said Laura Wilner, MD, Division Chief of Physical Medicine and Rehabilitation and Medical Director of Inpatient Rehabilitation at Phoenix Children's. "Rehabilitation services are crucial for patients and families at Phoenix Children's, and having a peer-reviewed stamp of approval from CARF is truly very exciting for the entire organization."

Phoenix Children's newest accreditation reflects the highest level of achievement awarded to an organization by CARF. To achieve it, the health system underwent a rigorous process that included an internal examination of both clinical and business practices, an on-site survey conducted by CARF-selected practitioners and the development of a Quality Improvement Plan. The Quality Improvement Plan demonstrates the organization's ability to address any areas for improvement.

"Our staff provides every patient with the therapies, resources and care they need to recover," said Elizabeth Linos, director of rehabilitation services at Phoenix Children's. "Our services may begin on the acute care floors, but that care continues beyond our patients' discharge dates."

The 12-bed Acute Inpatient Rehabilitation Program is a part of the Frances H. McClelland Pediatric Rehabilitation Department at Phoenix Children's. The largest pediatric rehabilitation department in the state, our team is focused on helping patients reach their optimal level of independence through family-centered care and a multi-disciplinary approach. The Acute Inpatient Rehabilitation Program accepts patients throughout the state and region and has recently added capabilities to care for patients on ventilator assistance who need intensive inpatient rehabilitation.

About Phoenix Children's Hospital
Phoenix Children's is Arizona's only children's hospital recognized by U.S. News & World Report's Best Children's Hospitals. For 35 years, Phoenix Children's has provided world-class inpatient, outpatient, trauma, emergency and urgent care to children and families in Arizona and throughout the Southwest. As one of the largest children's hospitals in the country, Phoenix Children's delivers care across more than 75 pediatric specialties. Recognized specifically for its patient-focused innovation, medical education, growth and research, Phoenix Children's was named Business of the Year and Exceptional Innovator by the Greater Phoenix Chamber in 2018. For more information about the Hospital, visit http://www.phoenixchildrens.org.

SOURCE Phoenix Children's Hospital


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: